Vyome Holdings, Inc. (HIND)
1.67
-0.03
(-1.76%)
USD |
NASDAQ |
Oct 28, 12:30
Vyome Holdings Cash from Operations (Quarterly) : -0.9037M for June 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.9037M |
| March 31, 2026 | -1.436M |
| December 31, 2025 | -1.478M |
| September 30, 2025 | 4.342M |
| June 30, 2025 | -0.3063M |
| March 31, 2025 | -0.2035M |
| December 31, 2024 | -0.003M |
| September 30, 2024 | 2.818M |
| June 30, 2024 | -1.357M |
| March 31, 2024 | -2.072M |
| December 31, 2023 | -2.457M |
| September 30, 2023 | -2.78M |
| June 30, 2023 | -6.662M |
| March 31, 2023 | -5.061M |
| December 31, 2022 | -2.829M |
| September 30, 2022 | -5.273M |
| June 30, 2022 | -6.422M |
| March 31, 2022 | -7.378M |
| December 31, 2021 | -3.426M |
| September 30, 2021 | -7.80M |
| Date | Value |
|---|---|
| June 30, 2021 | -2.188M |
| March 31, 2021 | -1.961M |
| December 31, 2020 | -1.762M |
| September 30, 2020 | -0.976M |
| June 30, 2020 | -0.998M |
| March 31, 2020 | -4.814M |
| December 31, 2019 | -4.879M |
| September 30, 2019 | -3.989M |
| June 30, 2019 | -4.356M |
| March 31, 2019 | -9.642M |
| December 31, 2018 | -5.415M |
| September 30, 2018 | -5.293M |
| June 30, 2018 | -8.122M |
| March 31, 2018 | -10.60M |
| December 31, 2017 | -9.197M |
| September 30, 2017 | -7.019M |
| June 30, 2017 | -6.055M |
| March 31, 2017 | -8.353M |
| December 31, 2016 | -5.775M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Cardiac Biotech Solutions, Inc. | -0.1918M |
| Anika Therapeutics, Inc. | -0.684M |
| Enovis Corp. | 75.03M |
| Edwards Lifesciences Corp. | 651.90M |
| Perspective Therapeutics, Inc. | -20.65M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Financing (Quarterly) | -0.003M |
| Free Cash Flow | 0.5245M |
| Free Cash Flow Per Share (Quarterly) | -0.1288 |
| Free Cash Flow to Equity (Quarterly) | -0.8985M |
| Free Cash Flow to Firm (Quarterly) | -0.9004M |
| Free Cash Flow Yield | 5.61% |